NF1 and colorectal carcinoma: In contrast, patients with NF1-mutated primary CRC tumors experienced significantly improved survival compared to their NF1 wild-type counterparts (p = 0.0000), suggesting a possible protective or distinct molecular role of NF1 in early-stage CRC biology (Figure S7).